IMM 2.94% 35.0¢ immutep limited

martin rogers in the us, page-3

  1. 2,084 Posts.
    I guess in US Mr Rogers would try to

    1. be sure the partners of PRR for IND application would do all of necessary works for IND application successful
    2. contact the US funds especially hedge funds to attract more risk capital into PRR
    3. meet CEO of DNDN if possible to get the first hand how to manage the Phase III trials for CVav
    4. discuss the divestment of the non-core business with the potential buyers.
    5. see some FDA officers as higher rank as possible to get more to break the huddles in the Phase III trials with FDA
    6. see the scenarios to produce CVav with some partner or make by PRR itself.
    ...

    Rogers has very practical and commercial hands with the ideas what should be got first, second, and then implement necessary tasks to be sure CVav Commercialization.

    It is marvelous for PRR to get the 12millioin funding which was not best one in price but strategically it is a base stone for PRR's future.

    I am quite enjoyed to see what PRR has been done since Mr Rogers started to be in charge.

    Lucks hit the prepared and persuaded minds. We do need to be patient.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
0.010(2.94%)
Mkt cap ! $515.6M
Open High Low Value Volume
34.0¢ 36.0¢ 33.5¢ $1.886M 5.392M

Buyers (Bids)

No. Vol. Price($)
38 218164 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 163204 24
View Market Depth
Last trade - 15.20pm 18/09/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.